Strand Therapeutics
PrivateLast Round
Series B
Mar 17, 2026
Est. Valuation
$550M
Total Funding Raised
$256M
Company Overview
Strand Therapeutics is a biotechnology company focused on developing gene therapies utilizing synthetic biology to create immunotherapies that enhance the immune system's ability to combat cancer by producing targeted cancer-killing proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strand Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Strand Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2026 | ||||
| Series B | Aug 7, 2025 | ||||
| Series A Extension | Nov 28, 2022 | ||||
| Series A | Jun 23, 2021 | ||||
| Seed | Jun 4, 2019 |
Key People
Founding team and executive leadership
Strand Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| ICONIQ Capital | Series B |
| Regeneron Ventures | Series B |
| Camford Capital | Series A |
| Playground Global | Series B, Series A Extension, Series A, Seed |
| LG Technology Ventures | Series B |
| ANRI株式会社 | Series B, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Lead program STX-001 now in Phase 1 trial for solid tumors.
- Aug 23, 2025
Dr. Jason J. Luke appointed as new Chief Medical Officer.
Strand Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Strand Therapeutics's valuation, stock price, and market status.
